Feider Stephen sold BBNX

November 9, 2026 · Form 4 insider transaction

Feider Stephen sold 744 shares of Beta Bionics, Inc. at $17.00 per share, a transaction worth $12.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.

Direction
Disposed (sell-side)
Shares
744
Price
$17.00
Total value
$12.6K
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateNovember 9, 2026
Filing dateNovember 12, 2026
Shares owned after159,378
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2026.; The weighted average sale price for the transaction reported was $17.001344 and the range of prices were between $17.00 and $17.01. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

View the original Form 4 on SEC EDGAR